// App-Quantinova.ai

P211 : An Interim Metagenomics Analysis of the International Multiple Sclerosis Microbiome Study (iMSMS)

Researchers

Presenter

  • Xiaoyuan Zhou

Principal Investigators

  • Xiaoming Jia

  • Mr. Patrick Barba

  • Mr. Ryan M Baumann

  • Patrizia Casaccia

  • Ilana Katz Sand

  • Zongqi Xia

  • Howard L Weiner

  • Tanuja Chitnis

  • Siddharthan Chandran

  • Siddharthan Connick

  • David Otaegui

  • Tamara Castillo-Trivio

  • Jorge Correale

  • Laura Negrotto

  • Mauricio Farez

  • Reinhard Hohlfeld

  • Jennifer S Graves

  • Bruce AC Cree

  • Stephen L Hauser

  • Rob Knight

  • Sergio E Baranzini

Medical Centers

  • University of California, San Francisco, San Francisco, CA

  • Icahn School of Medicine at Mount Sinai, New York, NY

  • University of Pittsburgh, Pittsburgh, PA

  • Ann Romney Center for Neurologic Diseases and Partners Multiple Sclerosis Center, Brigham and Women's Hospital, Department of Neurology, Harvard Medical School, Boston, MA

  • Brigham and Women’s Hospital Dept of Neurology, Partners MS Center, Harvard Medical School, Boston, MA

  • 1Neurology, Institute for Neurological Research Dr. Raúl Carrea (FLENI) Buenos Aires Argentina

  • Institute of Clinical Neuroimmunology,Biomedical Center and University Hospital, Ludwig-Maximilian-University Munich,Munich,German

  • University of California, San Diego, La Jolla, CA

Locations

  • United States

  • United Kingdom

  • Spain

  • Argentina

  • Germany

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Multiple Sclerosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Multinational

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved